Chen B P, Parham P
Department of Cell Biology, Stanford University, California 94305.
Nature. 1989 Feb 23;337(6209):743-5. doi: 10.1038/337743a0.
Activation of T lymphocytes requires the intracellular fragmentation of foreign antigens and their presentation by class I or class II major histocompatibility complex (MHC) glycoproteins. The direct binding of peptides to class II molecules has been demonstrated using equilibrium dialysis, gel filtration and fluorescence energy transfer at planar membranes, and its specificity compared to that of T-cell activation. In contrast, direct binding of peptides to class I molecules has been difficult to detect; although peptide sensitization experiments and the crystallographic structure of HLA-A2 (ref. 9) persuasively argue for its occurrence and importance. Here we describe a gel filtration assay from which we derive direct evidence for selective binding of an influenza matrix peptide to HLA-A2 and for binding of an influenza nucleoprotein peptide to HLA-B37. These two peptides have previously been shown to act respectively as targets for certain HLA-A2 or HLA-B37 restricted influenza-specific cytotoxic T lymphocytes (CTL). In addition we demonstrate binding to some, but not all, HLA allospecificities that cannot present these peptides to CTL. We estimate that less than 0.3% of the HLA molecules present in any given purified preparation were able to bind the added peptides.
T淋巴细胞的激活需要外来抗原在细胞内裂解,并由I类或II类主要组织相容性复合体(MHC)糖蛋白呈递。利用平衡透析、凝胶过滤和平面膜上的荧光能量转移技术,已证实肽与II类分子的直接结合,并将其特异性与T细胞激活的特异性进行了比较。相比之下,肽与I类分子的直接结合很难检测到;尽管肽致敏实验和HLA - A2的晶体结构(参考文献9)有力地证明了其存在和重要性。在此,我们描述了一种凝胶过滤测定法,从中我们获得了直接证据,证明流感基质肽与HLA - A2的选择性结合以及流感核蛋白肽与HLA - B37的结合。此前已表明这两种肽分别作为某些HLA - A2或HLA - B37限制性流感特异性细胞毒性T淋巴细胞(CTL)的靶标。此外,我们证明了与一些(但不是全部)不能将这些肽呈递给CTL的HLA同种特异性的结合。我们估计,在任何给定的纯化制剂中,不到0.3%的HLA分子能够结合添加的肽。